Reply to minimal clinically important difference and Edmonton Symptom Assessment Scale
Cancer
.
2016 Jan 1;122(1):159-60.
doi: 10.1002/cncr.29690.
Epub 2015 Sep 18.
Authors
David Hui
1
,
Eduardo Bruera
1
Affiliation
1
Department of Palliative Care and Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
PMID:
26383968
PMCID:
PMC4792538
DOI:
10.1002/cncr.29690
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Female
Humans
Male
Neoplasms / diagnosis*
Grants and funding
R01NR010162-01A1/NR/NINR NIH HHS/United States
R01 CA124481/CA/NCI NIH HHS/United States
R01CA122292-01/CA/NCI NIH HHS/United States
R21 CA186000/CA/NCI NIH HHS/United States
R21CA186000-01A1/CA/NCI NIH HHS/United States
R01 CA122292/CA/NCI NIH HHS/United States
R01 NR010162/NR/NINR NIH HHS/United States
R01CA124481-01/CA/NCI NIH HHS/United States